Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1985-12-20
1987-11-17
Siegel, Alan
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
549 62, A61K 3138, C07D33332
Patent
active
047074914
ABSTRACT:
.gamma.-Thiobutyrolactone derivatives having short chain .alpha.- and/or .gamma.-alkyl or alkenyl substituents have useful anticonvulsant properties.
REFERENCES:
patent: 3488732 (1970-01-01), Heiba
Klunk et al., Molecular Pharmacol. 22, 438-443, (1982).
Ferrendelli et al., Chem. Absts. 100: 9652b, (1984).
Klunk et al., Chem. Absts. 99:20579, (1983).
Klunk et al., Chem. Absts. 99: 17607, (1983).
Kendall and Wells, Chem. Absts, 81: 151465, (1974).
Gorski et al., Tetrahedron Lett. No. 30, pp. 2577-2580, (1976).
Stevens et al., J. Org. Chem. 19, pp. 1996-2003, (1954).
Overberger et al., J. Org. Chem. 27, pp. 3539-3545, (1962).
Tamaru et al., J. Amer. Chem. Soc. 106(4), pp. 1079-1085, (1984).
Bass et al., Tetrahedron 22(1), pp. 285-291, (1966).
Korte et al., Chem. Ber. 94, 1966-1976, (1961).
Aboul-Enein et al., Chem. Absts. 94: 103290.
Covey Douglas F.
Ferrendelli James A.
Levine Jeffrey A.
Meyer Scott J.
Siegel Alan
Washington University
Williams, Jr. James W.
LandOfFree
Anticonvulsant .gamma.-thiobutyrolactone derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anticonvulsant .gamma.-thiobutyrolactone derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anticonvulsant .gamma.-thiobutyrolactone derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1450397